HOOK | HOOKIPA Pharma Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	2.0000 - 2.1400
52 Week Range	1.8800 - 10.50
Beta	0.71
Implied Volatility	264.28%
IV Rank	39.21%
Day's Volume	73,259
Average Volume	51,814
Shares Outstanding	9,655,020
Market Cap	19,503,140
Sector	Healthcare
Industry	Biotechnology
IPO Date	2019-04-18

Valuation
Profitability
Growth
Health
P/E Ratio	-0.55
Forward P/E Ratio	N/A
EPS	-3.67
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	151
Country	USA
Website	HOOK

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.

HOOK's peers: ABOS, ALDX, ALT, ALZN, AMLX, APLT, ARDX, ATRA, BCTX, BIVI, CRVS, CTXR, CUE, DAWN, DMAC, DTIL, ELDN, EQ, ETNB, EYPT, MREO, TERN, PDSB, INZY, XFOR, HRTX, INKT, INVA, JSPR, KPTI, LPTX, LXRX, MEIP, MESO, MIST, MRSN, OCUL, ONCY, OTLK, PTGX, PYXS, QSI, SANA, SPRB, TSHA, UBX, VYGR, XERS, GPCR

*Chart delayed

Analyzing fundamentals for HOOK we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see HOOK Fundamentals page.

Watching at HOOK technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on HOOK Technicals page.